Compound Research Database

AOD-9604 is a synthetic 16-amino-acid fragment of human growth hormone (residues 177-191). Characterized in preclinical research on lipolysis-pathway and adipose-tissue mechanisms.

Methylcobalamin is the methylated bioactive form of vitamin B12. Used in preclinical research on one-carbon metabolism and homocysteine-pathway mechanisms.

Bacteriostatic water is sterile water containing 0.9 % benzyl alcohol as a bacteriostatic preservative. 10 ml vial - for larger-volume laboratory reconstitution of lyophilized research peptides.

Bacteriostatic water is sterile water containing 0.9 % benzyl alcohol as a bacteriostatic preservative. 3 ml vial - for laboratory reconstitution of lyophilized research peptides.

BPC-157 is a synthetic pentadecapeptide derived from gastric protective protein BPC. Among the most-cited compounds in preclinical tissue-modulation literature, with extensive in-vitro and animal-model characterization.

Combination of BPC-157 (gastric-protective pentadecapeptide) and TB-500 (thymosin beta-4 fragment). Studied in preclinical literature on combined tissue-modulation pathways.

Cagrilintide is a long-acting amylin analog peptide. Characterized in preclinical literature on amylin-receptor and pancreatic-pathway research.

CagriSema is a combined preparation of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Studied in published preclinical research on dual incretin / amylin-pathway mechanisms.

Combination of CJC-1295 (GHRH analog) and Ipamorelin (GHSR agonist). Investigated in preclinical research on dual-pathway GH-axis activation via two distinct receptor mechanisms.

CJC-1295 with DAC (drug-affinity complex) is a long-acting GHRH analog that binds serum albumin to extend half-life. Characterized in preclinical research on extended-duration GHRH-pathway models.

CJC-1295 without DAC is a modified GHRH analog with four amino-acid substitutions for enzymatic stability. Investigated in preclinical research on GHRH-receptor stimulation.

DSIP (Delta sleep-inducing peptide) is a nine-amino-acid endogenous peptide first isolated from rabbit cerebral venous blood. Studied in preclinical neuropeptide and circadian-pathway research.

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on the pineal peptide epithalamin. Studied in preclinical research on telomerase-expression and cellular-senescence pathways.

GHK-Cu is a naturally occurring tripeptide-copper complex (glycyl-L-histidyl-L-lysine bound to Cu²⁺). 100 mg vial for higher-volume research applications. Extensively characterized in preclinical copper-binding and tissue-pathway literature.

GHK-Cu is a naturally occurring tripeptide-copper complex (glycyl-L-histidyl-L-lysine bound to Cu²⁺). 50 mg vial. Among the most-cited tripeptides in preclinical copper-binding and tissue-pathway literature.

Three-peptide research blend (also known as the Wolverine Stack) combining GHK-Cu (tripeptide-copper complex), BPC-157 (gastric pentadecapeptide), and TB-500 (thymosin beta-4 fragment). Investigated in preclinical literature on combined tissue-modulation and copper-pathway mechanisms.

Semaglutide is a GLP-1 receptor agonist peptide with 94% sequence homology to human GLP-1. Characterized in extensive preclinical literature on incretin-pathway and glucose-homeostasis mechanisms.

Tirzepatide is a dual GIP / GLP-1 receptor agonist peptide. Extensively characterized in published preclinical and animal-model literature on dual-incretin-pathway research.

Retatrutide is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Studied in published preclinical work on multi-receptor incretin-pathway research.

Glutathione is the tripeptide antioxidant γ-Glu-Cys-Gly and the primary intracellular thiol redox buffer. Used in preclinical research on oxidative-stress and detoxification-pathway mechanisms.

Ipamorelin is a selective growth-hormone secretagogue receptor (GHSR) agonist pentapeptide. Studied in preclinical research on GH-axis receptor selectivity.

Four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV (alpha-MSH tripeptide). Characterized in preclinical literature on multi-pathway tissue and immune-modulation research.

KPV is the C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone. Studied in preclinical research on melanocortin and immune-pathway mechanisms.

Lipo-C is a combination preparation including L-carnitine, choline, and methyl-B12 (methylcobalamin). Studied in preclinical research on fatty-acid β-oxidation and methylation-pathway mechanisms.

LL-37 is a 37-amino-acid human cathelicidin-derived antimicrobial peptide. Characterized in preclinical literature on innate-immune and antimicrobial-pathway research.

Mazdutide is a dual GLP-1 / glucagon receptor agonist peptide. Investigated in preclinical research on combined incretin and glucagon-receptor pathways.

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH). Studied in preclinical research on melanocortin-receptor (MC1R, MC3R, MC4R) binding mechanisms.

MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded by 12S rRNA. Characterized in preclinical research on mitochondrial-function and metabolic-pathway mechanisms.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular redox reactions. Used in preclinical research on metabolism, sirtuin-pathway, and mitochondrial mechanisms.

PT-141 (Bremelanotide) is a melanocortin-receptor agonist heptapeptide, derived as a metabolite of Melanotan II. Characterized in preclinical research on MC3R / MC4R signaling pathways.

Selank is a synthetic heptapeptide analog of tuftsin. Characterized in preclinical literature on GABAergic neurotransmission and anxiolytic-pathway research.

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) fragment 4-7. Studied in preclinical research on neurotrophic-pathway and BDNF-expression mechanisms.

Sermorelin is a synthetic 29-amino-acid fragment representing the bioactive portion of growth-hormone-releasing hormone. Characterized in preclinical literature on GHRH-receptor research.

SS-31 (Elamipretide) is a synthetic mitochondria-targeted tetrapeptide that binds cardiolipin in the inner mitochondrial membrane. Investigated in preclinical research on mitochondrial bioenergetics pathways.

TB-500 is a synthetic fragment representing the active region of thymosin beta-4 (residues 17-23 of the full protein). Characterized in preclinical research on actin-binding and tissue-modulation pathways.

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH). Studied in published preclinical research on pituitary GH-secretion pathways.

Thymosin alpha-1 is a 28-amino-acid synthetic peptide derived from thymic prothymosin. Characterized in published preclinical research on T-cell and immune-pathway models.